Financial barriers in a county genetics clinic: Problems and solutions

J Genet Couns. 2020 Aug;29(4):678-688. doi: 10.1002/jgc4.1279. Epub 2020 Apr 10.

Abstract

A genetic evaluation may lead to a clinical or molecular diagnosis, which helps clarify prognosis, tailor surveillance protocols based on risks associated with the genetic condition, and aid in assessment of risk to family members. However, individuals of low socioeconomic and/or minority status often have limited access to genetics services, which contributes to healthcare disparities (Journal of Community Genetics, 2018, 9, 233). Our county hospital system, dedicated to providing health care to the underserved, offers a unique opportunity to reduce healthcare inequalities in genetics. This retrospective chart review included 2,304 patients evaluated at an outpatient county hospital genetics clinic between January 1, 2013, and December 31, 2018, during which time genetic testing was recommended for most patients (58.5%) for a total of 1,429 recommended genetic tests. Most tests were obtained through non-hospital financial resources (56.5%), and loss to follow-up during the phlebotomy stage was the most common reason for tests not to be ordered (41.9%) and not to be completed (36.4%). The experience in our clinic suggests that identifying financial avenues, such as commercial laboratory financial assistance programs in addition to county hospital funds, can support obtaining genetic testing and allow healthcare providers to overcome financial barriers to genetic testing.

Keywords: access; county genetics clinic; financial barriers; genetic testing; underrepresented populations.

MeSH terms

  • Ambulatory Care Facilities / economics*
  • Female
  • Financing, Personal*
  • Genetic Testing / economics*
  • Healthcare Disparities
  • Humans
  • Retrospective Studies